BioWorld

March 20, 2009

View Archived Issues

Cortex Slashing Half its Staff in Latest Round of Belt-Tightening

Cortex Pharmaceuticals Inc. is cutting about half its staff, slashing executive salaries and putting some research projects on the back burner, all in an effort to stay afloat in the troubled economy. (BioWorld Today) Read More

Genome Scan Studies Hold Promise for Cancer Research

Read More

Double-Duty Herceptin Variant Challenges Antibody Dogma

Read More

Arthritis: How Will it Impact the Biotech and Med-Tech Markets?

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Financings Roundup

Read More